Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT [NA]

View source ↗

Summary

A clinical trial update investigating LEAP2's role in glucose metabolism in obesity using total-body PET/CT; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEAP2 (LEAP2)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Obesity | NA | Status: ACTIVE_NOT_RECRUITING